Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-151883 |
Brand: | MCE |
CAS: | 2923433-95-6 |
MDL | - |
---|---|
Molecular Weight | 522.21 |
Molecular Formula | C9H12Cl2N4O5Pt |
SMILES | O[Pt](Cl)(Cl)(OC(C1=CC2=CC=CC([N+]([O-])=O)=C2N1)=O)([NH3])[NH3] |
APE1-IN-2 (compound AP1) can strongly inhibit the growth of malignant cells, including Cisplatin-resistant cancer cells, with up to 18.11 times inhibition compared with
Cisplatin
(HY-17394)
[1]
.
APE1-IN-2 (500 nM, 24 h) arrests the cell cycle in A549 and MCF7 cells
[1]
.
APE1-IN-2 (10 μM, 24 h) induces p53-dependent apoptosis in A549 cells
[1]
.
APE1-IN-2 (0-250 μM, 72 h) inhibits AP-cutting activity with an IC
50
of 45.14 ± 17.37 μM
[1]
.
APE1-IN-2 can directly inhibit the AP endonuclease activity of APE1, leading to an interruption of miRNA processing and upregulation of the tumor suppressor PTEN
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay [1]
Cell Line: | A549 (non-small cell lung cancer), MCF7 (breast cancer), U251 (glioblastoma), A375 (melanoma), PC3 (prostate cancer), and HEP-G2 (hepatocarcinoma) cell lines |
Concentration: | |
Incubation Time: | 72 h |
Result: | Demonstrated more potent antiproliferation effects than Cisplatin (HY-17394), with IC 50 of 0.45 ± 0.03, 0.43 ± 0.03, 4.70 ± 0.14, 0.39 ± 0.03, 5.65 ± 0.21, and 3.53 ± 0.31 μM in A549, MCF7, U251, A375, PC3, and HEP-G2 cell lines, respectively. |
Cell Cycle Analysis [1]
Cell Line: | A549 and MCF7 cells |
Concentration: | 500 nM |
Incubation Time: | 24 h |
Result: | Induced the most severe S-phase arrest in A549 and MCF7 cells. |
Cell Proliferation Assay [1]
Cell Line: | A549 cells |
Concentration: | 10 μM |
Incubation Time: | 24 h |
Result: | Caused apoptosis in approximately 38.7% (22.9% early apoptosis and 15.8% late apoptosis) of cancer cells. |
Western Blot Analysis [1]
Cell Line: | A549 and HEK-293T cell lines |
Concentration: | 0, 16, 40, 100, 250 μM |
Incubation Time: | 72 h |
Result: | Significantly increased the level of p53 by 2.09 ± 0.51-fold. Slightly raised the levels of p53, γH2A.X, and cl.PARP in HEK-293T. Inhibited AP-cutting activity with an IC 50 value of 45.14 ± 17.37 μM. |
APE1-IN-2 (compound AP1) (2 mg/kg, IP, once every 3 days for 15 days) exhibits an antitumor effect on the A549 xenograft model [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | BALB/c nude mice (5 week-old, female, 16 ± 2 g of body weight bearing A549 xenograft tumors) [1] |
Dosage: | 2 mg/kg |
Administration: | IP, once every 3 days for 15 days |
Result: | Exhibited a 3.86-fold xenograft tumor inhibitory activity compared to Cisplatin. Did not significantly alter the body weight of mice, improving its sufficient safety. |
Room temperature in continental US; may vary elsewhere.
Please store the product under the recommended conditions in the Certificate of Analysis.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.